International Stem Cell Corp - Current report filing (8-K)
March 31 2008 - 1:16PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): March 31, 2008
INTERNATIONAL
STEM CELL CORPORATION
(Exact
name of registrant as specified in its charter)
|
DELAWARE
|
|
0-51891
|
|
20-4494098
|
|
(State
or other Jurisdiction of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
|
2595
Jason Court
Oceanside,
CA
|
|
92056
|
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
(760) 940-6383
|
|
|
|
|
(Former
name or former address if changed since last
report.)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 8.01 Other
Events.
International
Stem Cell Corporation (OTCBB: ISCO) announced today that it has entered into an
agreement with ATCC (American Type Culture Collection, Manassas, Va.) to
manufacture living primary cells and cell culture products for worldwide
distribution by ATCC into the biological research market.
Item 9.01 Financial Statements
and Exhibits.
(d)
Exhibits.
|
Exhibit
|
|
|
|
Number
|
|
Description
|
|
99.1
|
|
Press
Release, dated March 31, 2008
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
|
|
|
|
|
INTERNATIONAL
STEM CELL CORPORATION
|
|
|
|
|
|
|
|
Dated:
March 31, 2008
|
|
By:
|
|
/s/
Jeffrey Janus
|
|
|
|
|
|
|
|
|
|
|
Name:
Jeffrey Janus
Title:
President International Stem Cell
Corporation
|
EXHIBIT INDEX
|
Exhibit
|
|
|
|
Number
|
|
Description
|
|
99.1
|
|
Press
Release, dated March 31, 2008
|
4
International Stem Cell (QB) (USOTC:ISCO)
Historical Stock Chart
From Jun 2024 to Jul 2024
International Stem Cell (QB) (USOTC:ISCO)
Historical Stock Chart
From Jul 2023 to Jul 2024
